This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Sep 17;224(6):1099-1100.

doi: 10.1093/infdis/jiab340.

Reply to Choe et al

Affiliations

PMID: 34161575
DOI: 10.1093/infdis/jiab340

Comment

Reply to Choe et al

Mai-Juan Ma. J Infect Dis. 2021.

. 2021 Sep 17;224(6):1099-1100.

doi: 10.1093/infdis/jiab340.

Author

Affiliation

¹ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.

PMID: 34161575
DOI: 10.1093/infdis/jiab340

No abstract available

PubMed Disclaimer

Comment on

Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
Choe PG, Kang CK, Kim KH, Yi J, Kim ES, Park SW, Kim NJ, Park WB, Oh MD. Choe PG, et al. J Infect Dis. 2021 Sep 17;224(6):1097-1099. doi: 10.1093/infdis/jiab339. J Infect Dis. 2021. PMID: 34166506 No abstract available.

Publication types

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems